BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35564855)

  • 1. Factors Associated with Colorectal Cancer Screening in Spain: Results of the 2017 National Health Survey.
    Nouni-García R; Lara-López Á; Carratalá-Munuera C; Gil-Guillén VF; López-Pineda A; Orozco-Beltrán D; Quesada JA
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey.
    Shapiro JA; Klabunde CN; Thompson TD; Nadel MR; Seeff LC; White A
    Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):895-904. PubMed ID: 22490320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to and predictors of participation in colorectal cancer screening with faecal occult blood testing in Spain, 2009-2011.
    Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López-de-Andrés A
    Eur J Cancer Prev; 2015 Jul; 24(4):305-12. PubMed ID: 25304027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.
    Chido-Amajuoyi OG; Sharma A; Talluri R; Tami-Maury I; Shete S
    Cancer Med; 2019 Dec; 8(17):7408-7418. PubMed ID: 31637870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
    Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
    World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
    Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
    Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal occult blood testing: people in Ontario are unaware of it and not ready for it.
    Ritvo P; Myers R; Del Giudice ME; Pazsat L; Cotterchio M; Howlett R; Mai V; Brown P; Sullivan T; Rabeneck L
    Can Fam Physician; 2009 Feb; 55(2):176-177.e4. PubMed ID: 19221081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The populations attitudes to colorectal cancer screening in the Czech Republic].
    Král N; Seifert B; Suchánek Š; Zavoral M; Májek O
    Epidemiol Mikrobiol Imunol; 2015 Mar; 64(1):41-6. PubMed ID: 25872995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal occult blood test and colonoscopy use in Portugal: Results from the National Health Survey 2014.
    Khan H; Shaaban N; Peleteiro B
    J Med Screen; 2020 Dec; 27(4):171-185. PubMed ID: 31865864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Screening Using Fecal Occult Blood Testing and Colonoscopy on the Risk of Colorectal Cancer: The Japan Public Health Center-based Prospective Study.
    Tanaka K; Sobue T; Zha L; Kitamura T; Sawada N; Iwasaki M; Inoue M; Yamaji T; Tsugane S
    J Epidemiol; 2023 Feb; 33(2):91-100. PubMed ID: 34053963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening.
    DeBourcy AC; Lichtenberger S; Felton S; Butterfield KT; Ahnen DJ; Denberg TD
    J Gen Intern Med; 2008 Feb; 23(2):169-74. PubMed ID: 18157581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE).
    Stock C; Brenner H
    Endoscopy; 2010 Jul; 42(7):546-56. PubMed ID: 20432204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors of Never Screened with Faecal Occult Blood Test in Public Primary Care Facilities.
    Sazali MF; Syed Abdul Rahim SS; Avoi R; Hassan MR; Hayati F; Azhar ZI; Jeffree MS; Awang Lukman K; Oo Tha N; Sajali H; Atil A; Abd Rahim MA
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):163-169. PubMed ID: 33507695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
    Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
    Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing colonoscopy behaviour among Koreans with a positive faecal occult blood tests.
    Choi E; Jeon J; Kim J
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e13008. PubMed ID: 30748048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test.
    Heresbach D; Manfredi S; D'halluin PN; Bretagne JF; Branger B
    Eur J Gastroenterol Hepatol; 2006 Apr; 18(4):427-33. PubMed ID: 16538116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population characteristics related to colorectal cancer testing in New South Wales, Australia: results from the 45 and Up Study cohort.
    Weber MF; Banks E; Ward R; Sitas F
    J Med Screen; 2008; 15(3):137-42. PubMed ID: 18927096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in colonoscopy and fecal occult blood test use after the introduction of dual screening offers in Germany: Results from a large population-based study, 2003-2016.
    Chen C; Stock C; Jansen L; Chang-Claude J; Hoffmeister M; Brenner H
    Prev Med; 2019 Jun; 123():333-340. PubMed ID: 30946858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.